Demant A/S (VIE:DEMA)

Market Cap	5.60B -32.2%
Revenue (ttm)	3.08B +2.5%
Net Income	206.87M -35.3%
EPS	0.98 -33.5%
Shares Out	n/a
PE Ratio	27.09
Forward PE	15.54
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	29.60
Previous Close	29.52
Day's Range	29.42 - 29.68
52-Week Range	27.88 - 39.12
Beta	n/a
RSI	29.49
Earnings Date	Feb 3, 2026

About Demant

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids and personalized hearing care products, as well as offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1904
• Employees: 22,057
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: DEMA

Financial Performance

In 2025, Demant's revenue was 22.97 billion, an increase of 2.46% compared to the previous year's 22.42 billion. Earnings were 1.55 billion, a decrease of -35.27%.

Financial numbers in DKK